concept

MICROGLIAL ACTIVATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MICROGLIAL ACTIVATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

483Connections

9Hypotheses

30Analyses

50Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MICROGLIAL ACTIVATION
Key Genes/Proteins	AIF1, Alpha-Synuclein, ALPHA-SYNUCLEIN, ALZHEIMER, AMYLOID, AMYLOID-BETA
Related Diseases	aging, ALS, Alzheimer Disease, Alzheimer'S Disease, ALZHEIMER'S DISEASE

Pathway Diagram

graph TD
    MICROGLIAL_ACTIVATION["MICROGLIAL ACTIVATION"]
    style MICROGLIAL_ACTIVATION fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    MICROGLIAL_ACTIVATION -->|"contributes to"| Neuromyelitis_Optica_Spectrum_["Neuromyelitis Optica Spectrum Disorders"]
    MICROGLIAL_ACTIVATION -->|"causes"| Inflammatory_Response["Inflammatory Response"]
    MICROGLIAL_ACTIVATION -->|"contributes to"| Neuroinflammation["Neuroinflammation"]
    MICROGLIAL_ACTIVATION -->|"contributes to"| Parkinson_s_Disease["Parkinson's Disease"]
    MICROGLIAL_ACTIVATION -->|"upregulates"| TREM2([TREM2])
    MICROGLIAL_ACTIVATION -->|"upregulates"| APOE([APOE])
    MICROGLIAL_ACTIVATION -->|"contributes to"| Ischemic_Stroke["Ischemic Stroke"]
    MICROGLIAL_ACTIVATION -->|"contributes to"| Tau_Pathology(Tau Pathology)
    MICROGLIAL_ACTIVATION -->|"contributes to"| Behavioral_Impairments(Behavioral Impairments)
    Amyloid_Beta["Amyloid Beta"] -->|"activates"| MICROGLIAL_ACTIVATION
    CKLF([CKLF]) -->|"causes"| MICROGLIAL_ACTIVATION
    Mitophagy["Mitophagy"] -->|"involved_in"| MICROGLIAL_ACTIVATION
    sTREM2["sTREM2"] -.->|"biomarker for"| MICROGLIAL_ACTIVATION
    NRF2([NRF2]) -->|"regulates"| MICROGLIAL_ACTIVATION
    defective_mitophagy(defective mitophagy) -->|"causes"| MICROGLIAL_ACTIVATION
    CKLF1([CKLF1]) -->|"causes"| MICROGLIAL_ACTIVATION
    Alpha_Synuclein_Aggregates["Alpha-Synuclein Aggregates"] -->|"causes"| MICROGLIAL_ACTIVATION
    APOE -->|"activates"| MICROGLIAL_ACTIVATION

Outgoing (145)

Target	Relation	Type	Str
Neurodegeneration	contributes_to	disease	0.92
Neuromyelitis Optica Spectrum Disorders	contributes_to	disease	0.91
Inflammatory Response	causes	process	0.90
Pro-inflammatory cytokine release	causes	process	0.90
A1 astrocyte conversion	drives	process	0.90
White Matter Injury	causes	disease	0.90
Nf-Κb/Nlrp3 Inflammasome Signaling	involved_in	pathway	0.90
Synaptic Elimination	mediates	process	0.90
oxidative stress	causes	mechanism	0.90
Neuroinflammation	contributes_to	process	0.90
mitochondrial DNA release	mediates	mechanism	0.90
Neuroinflammation	involved_in	process	0.88
SOD1-G93A	associated_with	gene	0.85
Parkinson'S Disease	contributes_to	disease	0.85
mitochondrial DNA release	associated_with	mechanism	0.85
Tau-Associated Neurodegeneration	mediates	phenotype	0.85
mitochondrial DNA release	causes	mechanism	0.85
APOE	upregulates	gene	0.85
cerebral ischemia-reperfusion injury	promotes	disease	0.85
TREM2	upregulates	gene	0.85
CXCL10 production	causes (microglial activation orchestrates CXCL10-mediated)	protein	0.85
NLRP3 Inflammasome	contributes_to	pathway	0.85
Cerebellar Neurodegeneration	contributes_to	phenotype	0.85
Parkinson's Disease	contributes_to	disease	0.85
neuronal excitability	inhibits	phenotype	0.85
Neuronal Loss	mediates	process	0.80
Behavioral Impairments	contributes_to	phenotype	0.80
Ischemic Stroke	contributes_to	disease	0.80
Dopaminergic Neurons	causes	cell_type	0.80
neuronal damage	contributes_to	phenotype	0.80
Neuroinflammation	mediates	process	0.80
Glucose Metabolic Alterations	associated_with	process	0.80
Tau Pathology	modulates	phenotype	0.80
Tau Pathology	contributes_to	phenotype	0.80
alzheimers	associated_with	disease	0.75
oxidative stress	associated_with	mechanism	0.75
Alzheimer's disease	associated_with	disease	0.70
TEMPORAL LOBE	associated_with	brain_region	0.70
neuroinflammation	activates	process	0.70
OLIGODENDROCYTE	activates	cell_type	0.70
DEPRESSION	regulates	disease	0.70
TNF	phosphorylates	gene	0.70
INFLAMMATION	protects_against	phenotype	0.70
OLIGODENDROCYTE	stabilizes	cell_type	0.70
NEURON	causes	cell_type	0.70
MITOCHONDRIAL DYSFUNCTION	exacerbates	phenotype	0.70
ALS	treats	disease	0.70
sepsis-associated encephalopathy	regulates	disease	0.70
NEURON	stabilizes	cell_type	0.70
STROKE	causes	disease	0.70

Incoming (338)

Source	Relation	Type	Str
C9orf72 Hexanucleotide Repeat Expansion	inhibits	mechanism	0.95
NFE2L2	regulates	gene	0.95
CKLF	causes	protein	0.95
GAL3	promotes	protein	0.95
Mitophagy	involved_in	process	0.95
sTREM2	biomarker_for	biomarker	0.93
REV-ERBα	regulates	protein	0.92
LAG3	mediates	protein	0.92
NRF2	regulates	gene	0.92
CKLF	causes	protein	0.90
Lgals3	drives	protein	0.90
HAVCR2	regulates	gene	0.90
NLRP3/JAK1/STAT3	mediates	pathway	0.90
Aβ	causes	protein	0.90
TREM2/DAP12	regulates	protein	0.90
CX3CL1	modulates	protein	0.90
OTUD1	activates	unknown	0.90
Lipopolysaccharide	activates	compound	0.90
HV1	involved_in	gene	0.90
sleep deprivation	causes	mechanism	0.90
AGER	activates	receptor	0.90
HK2	contributes_to	protein	0.90
LDLR overexpression	suppresses	process	0.90
TREM2	activates	protein	0.90
Gastrodin	inhibits	compound	0.90
CKLF1	causes	gene	0.90
MIR155	activates	gene	0.90
40806186	impair	paper	0.90
APOE ε2	inhibits	protein	0.90
37645718	exerts cell non-autonomous effect on	paper	0.90
39009412	was attenuated by	paper	0.90
39009412	attenuates	paper	0.90
Alpha-Synuclein Aggregates	causes	compound	0.90
HSYA	suppresses	compound	0.90
37645718	reduces	paper	0.90
defective mitophagy	causes	phenotype	0.90
HMGB1	activates	protein	0.90
Amyloid-beta aggregation	associated_with	process	0.90
APOE	activates	protein	0.90
Microbiota-Gut-Brain Axis	modulates	pathway	0.90
CX3CL1-CX3CR1 signaling	regulates	pathway	0.90
TREM2	mediates	protein	0.89
Amyloid-Β Deposition	correlates_with	phenotype	0.87
ANXA1	regulates	protein	0.85
TREM2	biomarker_for	protein	0.85
APOE	inhibits	protein	0.85
C3	upregulates	protein	0.85
CSF1R	modulates	gene	0.85
Chi3L1 Deletion	promotes	phenotype	0.85
AIF1	biomarker_for	gene	0.85

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2 Microglial Activation Rescues Amyloid Clearance in AD	0.682	neurodegeneration	Test Hypothesis Fixtures
TREM2-Independent Microglial Activation via CSF1R	0.659	neurodegeneration	Methodology challenge: dataset 'Allen Br
sex-divergent microglial activation states and X-linked immu	0.626	neurodegeneration	Sex-Specific Microglial States in Amyloi
TREM2-SYK microglial activation as a stage-specific Alzheime	0.610	neurodegeneration	Test
GluN2B-Mediated Microglial Activation and Tau Propagation	0.565	neuroscience	Circuit-level neural dynamics in neurode

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Acti	0.551	neuroinflammation	What molecular mechanisms mediate SPP1-i
CSF1R Agonism for TREM2-Independent Microglial Activation in	0.445	neurodegeneration	Test
GluN2B-Mediated Microglial Activation and Tau Phagocytosis	0.380	neuroscience	Circuit-level neural dynamics in neurode
Timed Melatonin Administration Exploits Circadian Vulnerabil	0.000	-	Microglia-astrocyte crosstalk amplificat

Mentioning Analyses (30)

Scientific analyses that reference this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

Sex-Specific Microglial States in Amyloid vs Tau Pathology and Cognitive Decline

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.675

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.585

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.728

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (8)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649]	Zhang J, St Pierre Schneider B, Muguerza	Am J Physiol Endocrinol Metab	2026
Interplay between CD33 and TREM2 in Alzheimer's Disease: Potential Mechanistic I [PMID:41388352]	["Akinluyi Elizabeth T", "Takahashi-Yama	ACS chemical neuroscience	2026
Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clear [PMID:35672148]	["Shi Qian", "Chang Cheng", "Saliba Afaf	The Journal of neuroscience :	2022
Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ. [PMID:35379353]	Unknown	Acta Neuropathol Commun	2022
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque cl [PMID:35921534]	["Zhao P", "Xu Y", "Fan X", "Li L", "Li	mAbs	2022
Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA re [PMID:31085626]	Unknown	EMBO Rep	2019
Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of N [PMID:24761931]	Unknown	Mol Brain	2014
Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyt [PMID:15212844]	Unknown	Neurobiol Aging	2004

Debates (20)

Multi-agent debates referencing this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

What sex-specific microglial transcriptional states emerge in response to amyloi

closed · Rounds: 4 · Score: 0.67 · 2026-04-28

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

closed · Rounds: 4 · Score: 0.54 · 2026-04-27

Related Research

Hypotheses and analyses mentioning MICROGLIAL ACTIVATION in their description or question text

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows

Score: 0.551 · neuroinflammation · 2026-04-20

## Mechanistic Overview Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows starts from the claim

CSF1R Agonism for TREM2-Independent Microglial Activation in ALS

Score: 0.445 · neurodegeneration · 2026-05-10

Proposed CSF1R agonism to activate neuroprotective microglial states avoiding TREM2-dependent inflammation. Fatal mechan

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

Score: 0.380 · neuroscience · 2026-04-27

This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance thro

Timed Melatonin Administration Exploits Circadian Vulnerability of Microglial Ac

Score: 0.000 · unknown disease · 2026-04-28

Since microglial IL-1α/TNF production follows circadian rhythms, precisely timed high-dose melatonin administration duri

MICROGLIAL ACTIVATION

Understanding Entity Pages

Pathway Diagram

Outgoing (145)

Incoming (338)

Targeting Hypotheses (9)

Mentioning Analyses (30)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

Sex-Specific Microglial States in Amyloid vs Tau Pathology and Cognitive Decline

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegen

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

Does tau dendritic missorting persist independently after Aβ clearance, maintain

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

scRNA-seq Processing and Cell Type Annotation of AD Brain

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia

Multi-modal Biomarker Panel Design for Early AD Detection

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

Which neural cell types exhibit the most pronounced gene expression alterations

Can circadian interventions selectively target microglia without affecting other

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxici

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

What biomarkers can reliably detect microglial priming states in living patients

Metabolomic signatures of neurodegeneration and energy metabolism dysfunction

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Investigate mechanisms of epigenetic reprogramming in aging neurons

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzheimer's Disease

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Circuit-level neural dynamics in neurodegeneration

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Experiments (0)

Related Papers (8)

Debates (20)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What sex-specific microglial transcriptional states emerge in response to amyloi

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

Related Research

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows

CSF1R Agonism for TREM2-Independent Microglial Activation in ALS

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

Timed Melatonin Administration Exploits Circadian Vulnerability of Microglial Ac